Investigators reviewed ocular side effects of semaglutide use from a global population-based study across 180 countries.

In 2 phase 3 studies, acoltremon 0.003% met primary endpoints, demonstrating statistically significant tear production at day 14.

Researchers compared the use of aflibercept 8 mg and 2 mg in patients with various retinal vein occlusion subtypes.

Researchers assessed the quality of life measures of patients with thyroid eye disease treated with Veligrotug, a full antagonist humanized mAb to IGF-1R.

The FDA has approved Epioxa™ HD 0.239% and Epioxa™ 0.177% for use in epithelium-on corneal collagen CXL for the treatment of ...

Researchers reviewed emergency department records to establish toy-related ocular injury trends among pediatric patients.

Explainable artificial intelligence (XAI) can identify clinically significant diabetic retinal neurodegeneration (DRN) on ...

The study published in JAMA Ophthalmology – the first epidemiologic study to home in on eye injuries in pickleball – reviewed ...

Investigators conducted a large-scale retrospective cohort study of the prevalence and age of onset of retinal detachment and ...

HealthDay News — For cancer survivors, postdiagnosis smoking cessation is associated with improved overall survival, according to a study published in the October issue of the Journal of the National ...

A phase 2 study supports the use of a microRNA eye drop for patients with corneal damage or dry eye disease.

Investigators reviewed the long-term outcomes of patients who completed the PANORAMA clinical trial and have since sought standard clinical care.